(Q38815462)

English

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

scientific article published on May 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

0 references

0 references

9

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Patrick McGorry

8

object named as

Patrick McGorry

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Assen V Jablensky

5

object named as

Assen Jablensky

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

author name string

Cherrie Galletly

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

David Castle

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Frances Dark

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Verity Humberstone

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Eóin Killackey

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jayashri Kulkarni

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Nga Tran

10

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

1 May 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Australian and New Zealand Journal of Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

410-472

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

The efficacy of electroconvulsive therapy in the treatment of schizophrenia. A comparative study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The neurobiology of social cognition

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Sex differences in the risk of schizophrenia: evidence from meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Effect of Nicotine Replacement Therapy on Agitation in Smokers With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Remission in schizophrenia: proposed criteria and rationale for consensus

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Gender differences in age at onset of schizophrenia. An overview

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Pharmacological approaches to treating negative symptoms: a review of clinical trials

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Contributions of neuropathology to understanding schizophrenia in late life

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Absence of Neurodegeneration and Neural Injury in the Cerebral Cortex in a Sample of Elderly Patients With Schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Peer workers' role in smoking-cessation groups for people with mental illness

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Evaluation of a community-based smoking cessation programme for people with severe mental illness

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Almost all antipsychotics result in weight gain: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Randomized Controlled Trial of a Healthy Lifestyle Intervention Among Smokers With Psychotic Disorders

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single-module programme

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Smoking cessation in people with schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A systematic review: Identifying the prevalence rates of psychiatric disorder in Australia's Indigenous populations

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Generalizability of the Individual Placement and Support (IPS) model of supported employment outside the US

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A meta-analysis of the risk for psychotic disorders among first- and second-generation immigrants

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Psychiatric comorbidities and schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The experiences of Australian parents with psychosis: the second Australian National Survey of Psychosis.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Schizophrenia and migration: a meta-analysis and review

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Sex and Schizophrenia: Effects of Diagnostic Stringency, and Associations with Premorbid Variables

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Best practice in early psychosis intervention for Australian indigenous communities: indigenous worker consultation and service model description

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Systematic meta-analysis of the risk factors for deliberate self-harm before and after treatment for first-episode psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Establishing sensory-based approaches in mental health inpatient care: a multidisciplinary approach

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Effects of stimulus intensity on the efficacy of bilateral ECT in schizophrenia: a preliminary study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The unchanging mortality gap for people with schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Demoralization: its phenomenology and importance

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Prolactin as an autocrine/paracrine factor in breast tissue

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Schizophrenia and older adults. An overview: directions for research and policy

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Social Cognition and Interaction Training (SCIT) for inpatients with schizophrenia spectrum disorders: preliminary findings

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Results of a Randomized Controlled Trial of Mental Illness Self-management Using Wellness Recovery Action Planning

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Tobacco smoking among people living with a psychotic illness: The second Australian survey of psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE).

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Chronic catatonic schizophrenia treated successfully with right unilateral ultrabrief pulse electroconvulsive therapy: case report

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A behavioral weight-loss intervention in persons with serious mental illness

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Global consensus statement on menopausal hormone therapy.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Evidence-based psychotherapy for schizophrenia: 2011 update

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The safety of medications for the treatment of bipolar disorder during pregnancy and the puerperium

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Criminally violent victimisation in schizophrenia spectrum disorders: the relationship to symptoms and substance abuse

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Research on the individual placement and support model of supported employment

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Quality of medical care and excess mortality in older patients with mental disorders

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Systematic review and meta-analysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A Maori perspective of health

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Negative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The evidence for illness progression after relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The nature of relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Gender difference in age at onset of schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Psychotic disorders and repeat offending: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Antipsychotics, mood stabilisers, and risk of violent crime

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and gender.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Initial medical work‐up of first‐episode psychosis: a conceptual review

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A systematic review of the evidence of clozapine's anti-aggressive effects.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Exposure-based cognitive-behavioral treatment of PTSD in adults with schizophrenia or schizoaffective disorder: a pilot study.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The psychosis high-risk state: a comprehensive state-of-the-art review

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Perceptions of clinicians treating young people with first-episode psychosis for post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Safety and tolerability of antipsychotic polypharmacy

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Accomplishments of the thought disordered person: a case study in psychiatrist-patient interaction.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Mental health starts with physical health: current status and future directions of non-pharmacological interventions to improve physical health in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: pilot results

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Confirming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal discordant twins

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The effect of group music therapy on quality of life for participants living with a severe and enduring mental illness.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Group music therapy for severe mental illness: a randomized embedded-experimental mixed methods study.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Catatonia in inpatients with psychiatric disorders: A comparison of schizophrenia and mood disorders

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Do former substance users with psychosis differ in their symptoms or function from non-substance users? A systematic meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Drugs of abuse and increased risk of psychosis development.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Sex-specific differences in side effects of psychotropic drugs: genes or gender?

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Effects of self-reported racial discrimination and deprivation on Māori health and inequalities in New Zealand: cross-sectional study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Recovery from psychotic illness: a 15- and 25-year international follow-up study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatio

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cost-effectiveness of early intervention in first-episode psychosis: economic evaluation of a randomised controlled trial (the OPUS study).

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Challenges of measuring the mental health of Indigenous Australians: honouring ethical expectations and driving greater accuracy

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Prevalence of mental illness among Aboriginal and Torres Strait Islander people in Queensland prisons.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

One hundred years of schizophrenia: a meta-analysis of the outcome literature.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Australian consumer perceptions of peer support.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Suicidal risk during treatment with clozapine: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Long delays in seeking treatment for schizophrenia.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Suicide and schizophrenia: a systematic review of rates and risk factors

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Disadvantage and discontent: a review of issues relevant to the mental health of rural and remote Indigenous Australians

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Indicators of psychoses or psychoses as indicators: the relationship between Indigenous social disadvantage and serious mental illness

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Psychosis in Indigenous populations of Cape York and the Torres Strait

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Antipsychotic-Induced Hyperprolactinaemia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Problems with non‐adherence to antipsychotic medication in Samoan new Zealanders: A literature review

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

An examination of patient-identified goals for treatment in a first-episode programme in Chennai, India

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A systematic review and meta-analysis of recovery in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Subtyping schizophrenia: implications for genetic research

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Integrated treatment of first-episode psychosis: effect of treatment on family burden: OPUS trial

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Aging and outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The key to reducing duration of untreated first psychosis: information campaigns

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Psychotic symptoms and population risk for suicide attempt: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Obstructive sleep apnea and incident diabetes. A historical cohort study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Mindfulness interventions for psychosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Effectiveness of early intervention in psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Vocational intervention in first-episode psychosis: individual placement and support v. treatment as usual

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cognitive behavioural group treatment for social anxiety in schizophrenia.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Clinical review of a long-acting, injectable formulation of risperidone

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Prevalence of alcohol use disorders in schizophrenia--a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Estrogen in severe mental illness: a potential new treatment approach

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Social Cognitive Training for Schizophrenia: A Meta-Analytic Investigation of Controlled Research

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cognitive and social cognitive predictors of change in objective versus subjective quality-of-life in rehabilitation for schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Neurocognitive Impairment in Obstructive Sleep Apnea

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cannabis Use and Earlier Onset of Psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The predictive value of risk categorization in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

At issue: Sex and gender in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Community treatment orders in Australia: rates and patterns of use.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The clinical challenges of akathisia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Trauma and posttraumatic stress disorder (PTSD) in patients with schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Insight in schizophrenia and risk of suicide: a systematic update.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Treating comorbid substance use disorders in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Skill building: assessing the evidence

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Economic impact of services for first-episode psychosis: a decision model approach

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Schizophrenia: a concise overview of incidence, prevalence, and mortality

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cognitive remediation and vocational rehabilitation

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Late-onset schizophrenia: do recent studies support categorizing LOS as a subtype of schizophrenia?

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Severe mental illness and criminal victimization: a systematic review

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The case for social-cognitive remediation in schizophrenia: a life well lived is more than remission from psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Smoking and mental illness. An update for psychiatrists

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The impact of alcohol and illicit drugs on people with psychosis: The second Australian national survey of psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Do women express and experience psychosis differently from men? Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Sociodemographic, clinical and childhood correlates of adult violent victimisation in a large, national survey sample of people with psychotic disorders

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

People living with psychotic illness in 2010: the second Australian national survey of psychosis.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Treatment of co-occurring psychotic and substance use disorders

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Obstructive sleep apnea and schizophrenia: A systematic review to inform clinical practice

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

What difference a decade? The costs of psychosis in Australia in 2000 and 2010: comparative results from the first and second Australian national surveys of psychosis.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Costs of psychosis in 2010: findings from the second Australian National Survey of Psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The employment of consumers in mental health services: politically correct tokenism or genuinely useful?

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Rates of homicide during the first episode of psychosis and after treatment: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Country of birth and hospital treatment for psychosis in New South Wales

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Overview of violence to self and others during the first episode of psychosis.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Symptom and functional outcomes for a 5year early intervention program for psychoses

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The puzzle of schizophrenia: tracking the core role of cognitive deficits

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Premature Mortality Among Adults With Schizophrenia in the United States.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Relative incidence of common cancers in people with severe mental illness. Cohort study in the United Kingdom THIN primary care database

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The Lifetime Risk of Suicide in Schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Adult obstructive sleep apnea: pathophysiology and diagnosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Prolactin and antipsychotic medications: mechanism of action

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Double-blind randomized controlled study showing symptomatic and cognitive superiority of bifrontal over bitemporal electrode placement during electroconvulsive therapy for schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Clozapine resistance: augmentation strategies

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Suicide prevention in first episode psychosis: the development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Effect of atypical antipsychotics on fetal growth: is the placenta involved?

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Life and treatment goals of individuals hospitalized for first-episode nonaffective psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Patterns of service utilisation in psychosis: findings of the 2010 Australian national survey of psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

First episode psychosis and employment: a review

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A randomized, controlled trial of Social Cognition and Interaction Training (SCIT) for outpatients with schizophrenia spectrum disorders.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Older people with schizophrenia: a community study in a rural catchment area

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The cognitive effects of electroconvulsive therapy in community settings

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A Systematic Review of Mortality in Schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A systematic review of the prevalence of schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Differences in patients' perceptions of Schizophrenia between Māori and New Zealand Europeans

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cannabis and stimulant disorders and readmission 2 years after first-episode psychosis.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Secondary effects of antipsychotics: women at greater risk than men.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Treating schizophrenia at the time of menopause

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Clinical interventions for women with schizophrenia: pregnancy

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The role of estrogens in schizophrenia gender differences

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Is schizophrenia a dopamine supersensitivity psychotic reaction?

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Open dialogues with good and poor outcomes for psychotic crises: examples from families with violence

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The social defeat hypothesis of schizophrenia: an update

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Measures of personal recovery: a systematic review

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Treatment of postpartum psychosis: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A randomised controlled trial of acceptance-based cognitive behavioural therapy for command hallucinations in psychotic disorders

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A clinical review of the treatment of catatonia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Psychoeducational interventions for family members of people with schizophrenia: a mixed-method systematic review.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The contribution of mental health services to recovery

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Early interventions to prevent psychosis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Physical health algorithms for mental health care.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The effect of drug use on the age at onset of psychotic disorders in an Australian cohort

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Reconceptualizing schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cognitive Profile Difference Between Allen Cognitive Levels 4 and 5 in Schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Genetic architectures of psychiatric disorders: the emerging picture and its implications

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Interventions to reduce antipsychotic polypharmacy: a systematic review

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Transcranial direct current stimulation to enhance cognitive remediation in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Psychiatric disorders in homeless men and women in inner Sydney.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: Neurophysiology

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocol

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Physical health disparities and mental illness: the scandal of premature mortality

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Gender differences in response to antipsychotic treatment in outpatients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Is late-onset schizophrenia a subtype of schizophrenia?

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Meta-analysis of the association of urbanicity with schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A brief cognitive assessment for use with schizophrenia patients in community clinics

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

'Earning and learning' in those with psychotic disorders: the second Australian national survey of psychosis.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Pubertal neurodevelopment and the emergence of psychotic symptoms

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Measures of the recovery orientation of mental health services: systematic review.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Substance Use Disorder Among People With First-Episode Psychosis: A Systematic Review of Course and Treatment

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Gender differences in tardive dyskinesia: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Severe non-lethal violence during psychotic illness.

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Long-term follow-up of all-cause and unnatural death in young people with first-episode psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Systematic reviews of assessment measures and pharmacologic treatments for agitation

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The Diagnosis of Psychosis

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Mortality in Western Australian psychiatric patients

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

The Critical Period for Early Intervention

1 reference

https://api.crossref.org/works/10.1177/0004867416641195

21 January 2018

Identifiers

10.1177/0004867416641195

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38815462&oldid=2269583850"